Drug Approval | March 14, 2024
Zydus receives USFDA final approval for chlorpromazine hydrochloride injection
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The institution will be spread over an area of more than 8 acres
ANVISA issues CGMP to Concord Biotech’s Unit I
BHL will undertake the development and supply of these molecules
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Subscribe To Our Newsletter & Stay Updated
